Neuromyelitis optica spectrum disorder (NMOSD) is a rare but severe neuroinflammatory disease requiring rapid diagnosis and prompt treatment to prevent irreversible disability. In this expert-led webinar, Vincent van Pesch explores the latest advances in NMOSD diagnosis and management, with a particular focus on clinical practice in Belgium. The webinar is introduced and moderated by Melissa Cambron.

The session covers diagnostic red flags, imaging features, antibody testing, and evolving therapeutic strategies that are reshaping patient care.

Learning Objectives

After watching this webinar, clinicians will be able to:

• Recognise the key clinical and radiological features of NMOSD
• Differentiate NMOSD from multiple sclerosis and MOG-associated disease
• Understand the role of aquaporin-4 antibody testing in diagnosis
• Identify optimal strategies for managing acute NMOSD relapses
• Evaluate emerging targeted therapies for long-term disease prevention

The Clinical Management of NMOSD in Belgium

Please subscribe to watch.

Log-in on subscribe

Find out more about the speakers:

Vincent van Pesch

Professor of Neurology and Associate Head of the Neurology department of the Cliniques Universitaires Saint-Luc

Dr Van Pesch obtained his medical degree in 1999 from Université Catholique de Louvain and then completed his PhD thesis in neuroimmunology in 2003. He served as neurology resident at Department of Neurology, Saint-Luc Hospital and then progressed in positions from Adjunct Clinical Head to Associate Clinical Head and finally to Adjunct Chief of Neurology Department at Cliniques Universitaires Saint-Luc. He is also responsible for a number of other services within the same place such as coordination and supervision of the neurophysiology unit and supervision and teaching of electroencephalography and evoked potentials to neurology residents.

At Université Catholique de Louvain, Dr Van Pesch is a Profssor of Neurology and is responsible for teaching neuroimmunology and cerebrospinal fluid/neurochemistry analysis as he is the Principal investigator at Neurochemistry Unit at UCL.

Dr Van Pesch also greatly contributes to scientific publications and has over 200 published papers in a number of renowned journals. He is also co-editor of Frontiers Neurology, section of Multiple Sclerosis and neuroimmunology and section of Neuroepidemiology and also Co-editor of the Acta Neurologica Belgica.

Melissa Cambron

MD, PhD, neuroinflammatory specialist at AZ Sint-Jan Bruges

Melissa Cambron, MD, PhD, is a neuroinflammatory specialist at AZ Sint-Jan Bruges, a position she has held since 2018, and is affiliated with Ghent University. She completed her specialization and obtained her PhD at the Vrije Universiteit Brussel (VUB). Dr. Cambron further expanded her clinical and academic expertise through a one-year fellowship in neurology at CHRU Lille under the supervision of Professor Patrick Vermersch. Her clinical and research interests focus on neuroinflammatory and neuroimmunological disorders, including neuromyelitis optica spectrum disorders.

Sponsor

This educational material is based on the recording of a webinar. The webinar was sponsored by Alexion. Alexion was not involved in the elaboration of the presentations.

We value your opinion.

How likely are you to recommend this material to a friend or colleague?

Selected Value: 1

Give a score from 1 (= not at all likely) to 10 (extremely likely)

Tell us what you think or ask a question to the expert.

Give your opinion on the quality of the material and send us your comments, questions or feedback. Where relevant, we'll liaise with the Expert and get back to you.

Email

If you have submitted a question above, leave your email so we can get back to you.

Hidden a ask

Submit